This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This new system combines a truly innovativestent design,” said Dr. Ramaiah, a former director of the Arizona Heart Hospital. “We She already has three stents in her heart and so many stents and replacement arteries in both her legs that she’s lost count. Designed by Raleigh, N.C.-based based Contego Medical Inc.,
milla1cf Wed, 04/17/2024 - 16:18 April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered stent system, which has been on the market for twenty years and recently received premarket approval for treatment of iliac arterial occlusive disease.
and an investigator in the VIVID study , which contributed to the device’s FDA approval – successfully used the Duo Venous Stent System for the first time outside of a clinical trial. Duo Hybrid has a distinct integrated design that combines multiple zones of differing mechanical properties into a single stent [3].
based HonorHealth Research and Innovation Institute is among the first facilities in the nation — and one of 30 worldwide — to use new stroke prevention stents, according to a May 29 news release. Scottsdale, Ariz.-based
(Gore) announced recent FDA approval of a lower profile GORE VIABAHN VBX Balloon Expandable Endoprosthesis ( VBX Stent Graft ). FDA approval of this innovation builds on a proven device which has become an important tool for treating complex vascular disease. No changes to the stent design were made to achieve the lower profile.
The prospective, international, multicenter single-arm observational study evaluated the treatment of de novo, restenotic or occluded iliac lesions in 160 patients with Rutherford Class 2-6 peripheral artery disease using the Dynetic-35 cobalt chromium balloon-expandable stent system. At baseline, 12.5% stenosis in the target lesion. “The
With the FDA nod, Abbott can now evaluate the IVL system in treating severe calcification in coronary arteries prior to stenting. Abbotts new IVL IDE was two years in the making following its $890M acquisition of Cardiovascular Systems in 2023 that gave the medtech giant an entry into the IVL arena.
milla1cf Mon, 05/06/2024 - 10:55 May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative patient care in the cardiovascular segment has announced a strategic partnership with HeartX , a pioneering MedTech company focused on research and development.
Textile-based sensors and polymer-based stents came out on top in this year's annual Innovation Pitch Challenge, part of the Future Hub activities organized by the College's Health Care Innovation Section.
Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. Around 10% of Deaths from Coronary Stenting, Balloon Angioplasty are Preventable 9. Here is a look at what DAIC viewers were reading last month: 1. EMPACT-MI Trial Outcomes Reported at ACC.24:
1 To date, interventional treatment of coronary artery disease with drug-eluting stents has been able to establish flow angiographically. 2 “For many years, it was thought that caging of the vessel with stents was the main driver for annual increasing non-plateauing event rates. of the U.S. population. JACC 2020. 5 Saito S, et al.
milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. Surgical aortic valve replacement with a stented pericardial bioprosthesis: 5-year outcomes. February 18–21, 2024.
Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. Surgical aortic valve replacement with a stented pericardial bioprosthesis: 5-year outcomes. February 18–21, 2024.
For CCTA to be truly effective, the CT system must be designed to address the most difficult cardiac exams, including irregularities in heart rhythms, patients with limited cooperation, and those with calcification, stents or bypasses. viii, ix, x, xi, xii, xiii, xiv, xv GE HealthCaredesigned Revolution Vibe to address these challenges.
BackgroundThe rapid evolution of artificial intelligence (AI) in conjunction with recent updates in dual antiplatelet therapy (DAPT) management guidelines emphasizes the necessity for innovative models to predict ischemic or bleeding events after drug‐eluting stent implantation.
If a physician fails to cross a CTO, minimally invasive revascularization options such as angioplasty and stent placement cannot be performed. We are committed to advancing the field of interventional cardiology and improving patient outcomes through innovation." Hence, in the US, many CTO patients are instead sent for bypass surgery.
The newly CE launched Freesolve RMS for coronary artery lesions, based on the BIOmag magnesium alloy and the proven Orsiro drug-eluting stent (DES) coating technology, provides safety, improved deliverability, and optimal performance and vessel support during and after implantation.2,3 2,3 It has shown 99.6%
We’re excited to collaborate with Medis Medical Imaging to add innovative, non-invasive, image-based QFR to our portfolio of offerings around our Allia IGS platform to streamline the experience for clinicians and help us to deliver on our vision for the future image-guided therapy.”
Guidewires are the backbone of the aortic procedure, facilitating tracking through patient anatomy and delivering the stent graft to the landing zone. The ideal wire is a balance of deliverability with patient safety,” said Patrick Muck, MD, vascular surgeon, TriHealth Heart Institute.
The teams will combine innovative engineering designs, antithrombotic slippery hydrophilic (SLIC) coatings, wireless power transfer systems, magnetically levitated driving systems and preclinical device testing to achieve their goal. Through a new four-year, $7.8 Department of Veterans Affairs.
Featured topics will include in-depth sessions covering non-statin lipid lowering therapies, heart failure with preserved ejection fraction, viability, imaging modalities for the assessment of coronary artery disease, and antiplatelet therapy after coronary stenting. ACC has planned the following meetings and events throughout ACC.24,
With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD). It is currently undergoing clinical studies in the U.S.
IVUS reveals plaque characteristics, optimal stent usage, and vessel measurements. On the other hand, OCT, with its microscopic accuracy, unveils fine stent positioning and tissue reactions. Regular training acts as your compass in the ever-changing world of medical innovations.
Nature Reviews Cardiology, Published online: 02 April 2024; doi:10.1038/s41569-024-01020-2 In ST-segment elevation myocardial infarction, the role of interventional modification of thrombi in the coronary arteries before stenting is controversial.
Doctors then treat the cause of the heart attack, either inserting a stent, removing a clot or taking other necessary action. The Impella® heart pump, an FDA-approved device, is inserted through a catheter in the groin as soon as the patient arrives at the hospital. Division Head of Cardiology at Henry Ford Health.
The results of our validation studies show this innovative test demonstrates outstanding intra (2 percent) and inter (10 percent) test variation, well below the current FDA guidance (25 percent)," said Dr. David Schneider Prolocor Co-Founder and Chief Science Officer. tim.hodson Tue, 09/10/2024 - 13:34 Sept. 5,2024 - Prolocor, Inc.
For example, interventional cardiologists can benefit from simulation labs that mimic complex cardiovascular procedures, allowing them to practice catheter insertion techniques or stent placements before applying them in a live setting.
Fellows 2024 offers hands-on training covering revascularization, angioplasty, stents, pharmacologic therapy, and intravascular imaging/physiology. The conference features live demonstrations, training workshops, simulations, clinical cases, late-breaking trials, innovations, and selected scientific abstracts.
This article will explore how AI-driven diagnostics are reshaping cardiovascular medicine and how can healthcare leaders can leverage these innovations to improve patient care and control costs. These costs represent a massive portion of total health expenditures.
For example, interventional cardiologists can benefit from simulation labs that mimic complex cardiovascular procedures, allowing them to practice catheter insertion techniques or stent placements before applying them in a live setting.
Research was funded by Germany's Federal Joint Committee Innovation Fund (funding reference number 01VSF19016). Emergency CEA and carotid stenting procedures were excluded from the analysis. A total of 119800 patients remained in the analysis.
Here comes the real Innovation. Fibro-Optic real shape( FORS) technology , which reconstructs image from optical data, and beam live fluro- like images, in 3 dimension. May be, we may soon, say good bye to electrons, protons, and welcome these harmless photons.
February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes.
Moving forward, this innovative tool could be applied proactively to future clinical trials. Yet, the risk factors among patients that are randomized might not always be equally distributed such that a bias may occur.
Besides, the latest innovations in the health tech sector, like , Wellnest ECG Pro 2 , enable doctors to conduct ECG within minutes through the auto-placement of Electrodes in times of such emergencies! Then angioplasty is performed, and a medical device called a stent (metallic scaffold) is deployed in the artery to open the blood flow.
OCT, the magical intraluminal coronary vision, has been a great innovation that helps us to decode many uncertainties in the morphology, behavior and vulnerability of coronary plaques. It is used widely in pre- or post-PCI or even asssit during the implantation of stents. Reference 1. Gonzalo N, Serruys PW, Piazza N, Regar E.
August 2024 Approvals Minima Stent System (P240003) (Approval Date: August 28, 2024) The Minima Stent System is an expandable cobalt-chromium metal mesh tube to reopen blood vessels in neonates, infants, and children with Coarctation of the Aorta and Pulmonary Artery Stenosis, specifically designed to expand as younger patients grow.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content